A Therapeutic and Diagnostic Multidisciplinary Pathway for Merkel Cell Carcinoma Patients

Marco Rastrelli; Paolo Del Fiore; Alessandra Buja; Antonella Vecchiato; Carlo Riccardo Rossi; Vanna Chiarion Sileni; Saveria Tropea; Francesco Russano; Manuel Zorzi; Romina Spina; Rocco Cappellesso; Renzo Mazzarotto; Francesco Cavallin; Franco Bassetto; Elisabetta Bezzon; Beatrice Ferrazzi; Mauro Alaibac; Simone Mocellin

doi:10.3389/fonc.2020.00529

A Therapeutic and Diagnostic Multidisciplinary Pathway for Merkel Cell Carcinoma Patients

Marco Rastrelli, Paolo Del Fiore, Alessandra Buja, Antonella Vecchiato, Carlo Riccardo Rossi, Vanna Chiarion Sileni, Saveria Tropea, Francesco Russano, Manuel Zorzi, Romina Spina, Rocco Cappellesso, Renzo Mazzarotto, Francesco Cavallin, Franco Bassetto, Elisabetta Bezzon, Beatrice Ferrazzi, Mauro Alaibac, Simone Mocellin

Istituto Oncologico Veneto

Research output: Contribution to journal › Article › peer-review

Abstract

Merkel Cell Carcinoma (MCC) is a highly aggressive neuroendocrine neoplasm of the skin. Due to its rarity, the management of MCC is not standardized across centers. In this article, we present the experience of the Veneto region in the North-East of Italy, where a committee of skin cancer experts has proposed a clinical pathway for the diagnosis and treatment of MCC. Putting together the evidence available in the international literature, we outlined the best approach to the management of patients affected with this malignancy step- by- step for each possible clinical situation. Crucial in this pathway is the role of the multidisciplinary team to deal with the lack of robust information on each aspect of the management of this disease.

Original language	English
Article number	529
Number of pages	8
Journal	Frontiers in Oncology
Volume	10
DOIs	https://doi.org/10.3389/fonc.2020.00529
Publication status	Published - Apr 15 2020

Access to Document

10.3389/fonc.2020.00529

Cite this

Rastrelli, M., Del Fiore, P., Buja, A., Vecchiato, A., Rossi, C. R., Chiarion Sileni, V., Tropea, S., Russano, F., Zorzi, M., Spina, R., Cappellesso, R., Mazzarotto, R., Cavallin, F., Bassetto, F., Bezzon, E., Ferrazzi, B., Alaibac, M., & Mocellin, S. (2020). A Therapeutic and Diagnostic Multidisciplinary Pathway for Merkel Cell Carcinoma Patients. Frontiers in Oncology, 10, [529]. https://doi.org/10.3389/fonc.2020.00529

Rastrelli, M , Del Fiore, P, Buja, A, Vecchiato, A, Rossi, CR, Chiarion Sileni, V , Tropea, S , Russano, F, Zorzi, M, Spina, R, Cappellesso, R, Mazzarotto, R, Cavallin, F, Bassetto, F, Bezzon, E, Ferrazzi, B, Alaibac, M & Mocellin, S 2020, 'A Therapeutic and Diagnostic Multidisciplinary Pathway for Merkel Cell Carcinoma Patients', Frontiers in Oncology, vol. 10, 529. https://doi.org/10.3389/fonc.2020.00529

@article{378cac3c32f04743a309716ab861be79,

title = "A Therapeutic and Diagnostic Multidisciplinary Pathway for Merkel Cell Carcinoma Patients",

abstract = "Merkel Cell Carcinoma (MCC) is a highly aggressive neuroendocrine neoplasm of the skin. Due to its rarity, the management of MCC is not standardized across centers. In this article, we present the experience of the Veneto region in the North-East of Italy, where a committee of skin cancer experts has proposed a clinical pathway for the diagnosis and treatment of MCC. Putting together the evidence available in the international literature, we outlined the best approach to the management of patients affected with this malignancy step- by- step for each possible clinical situation. Crucial in this pathway is the role of the multidisciplinary team to deal with the lack of robust information on each aspect of the management of this disease.",

author = "Marco Rastrelli and {Del Fiore}, Paolo and Alessandra Buja and Antonella Vecchiato and Rossi, {Carlo Riccardo} and {Chiarion Sileni}, Vanna and Saveria Tropea and Francesco Russano and Manuel Zorzi and Romina Spina and Rocco Cappellesso and Renzo Mazzarotto and Francesco Cavallin and Franco Bassetto and Elisabetta Bezzon and Beatrice Ferrazzi and Mauro Alaibac and Simone Mocellin",

note = "Copyright {\textcopyright} 2020 Rastrelli, Del Fiore, Buja, Vecchiato, Rossi, Chiarion Sileni, Tropea, Russano, Zorzi, Spina, Cappellesso, Mazzarotto, Cavallin, Bassetto, Bezzon, Ferrazzi, Alaibac and Mocellin.",

year = "2020",

month = apr,

day = "15",

doi = "10.3389/fonc.2020.00529",

language = "English",

volume = "10",

journal = "Frontiers in Oncology",

issn = "2234-943X",

publisher = "Frontiers Media S. A.",

}

TY - JOUR

T1 - A Therapeutic and Diagnostic Multidisciplinary Pathway for Merkel Cell Carcinoma Patients

AU - Rastrelli, Marco

AU - Del Fiore, Paolo

AU - Buja, Alessandra

AU - Vecchiato, Antonella

AU - Rossi, Carlo Riccardo

AU - Chiarion Sileni, Vanna

AU - Tropea, Saveria

AU - Russano, Francesco

AU - Zorzi, Manuel

AU - Spina, Romina

AU - Cappellesso, Rocco

AU - Mazzarotto, Renzo

AU - Cavallin, Francesco

AU - Bassetto, Franco

AU - Bezzon, Elisabetta

AU - Ferrazzi, Beatrice

AU - Alaibac, Mauro

AU - Mocellin, Simone

PY - 2020/4/15

Y1 - 2020/4/15

N2 - Merkel Cell Carcinoma (MCC) is a highly aggressive neuroendocrine neoplasm of the skin. Due to its rarity, the management of MCC is not standardized across centers. In this article, we present the experience of the Veneto region in the North-East of Italy, where a committee of skin cancer experts has proposed a clinical pathway for the diagnosis and treatment of MCC. Putting together the evidence available in the international literature, we outlined the best approach to the management of patients affected with this malignancy step- by- step for each possible clinical situation. Crucial in this pathway is the role of the multidisciplinary team to deal with the lack of robust information on each aspect of the management of this disease.

AB - Merkel Cell Carcinoma (MCC) is a highly aggressive neuroendocrine neoplasm of the skin. Due to its rarity, the management of MCC is not standardized across centers. In this article, we present the experience of the Veneto region in the North-East of Italy, where a committee of skin cancer experts has proposed a clinical pathway for the diagnosis and treatment of MCC. Putting together the evidence available in the international literature, we outlined the best approach to the management of patients affected with this malignancy step- by- step for each possible clinical situation. Crucial in this pathway is the role of the multidisciplinary team to deal with the lack of robust information on each aspect of the management of this disease.

U2 - 10.3389/fonc.2020.00529

DO - 10.3389/fonc.2020.00529

M3 - Article

C2 - 32351898

SN - 2234-943X

VL - 10

JO - Frontiers in Oncology

JF - Frontiers in Oncology

M1 - 529

ER -

A Therapeutic and Diagnostic Multidisciplinary Pathway for Merkel Cell Carcinoma Patients

Abstract

Access to Document

Fingerprint

Cite this